Member Posts > Cardiol Therapeutics: An Overlooked Biotech with Strong Upside
🔬 CBD-based therapies for heart disease
📈 FDA orphan drug status for CardiolRx™
💰 $15.9M in cash, $99M market cap
⚡ Upcoming trial data & partnerships = Growth catalysts
Stock trades at $1.18 (Feb 19, 2025).

#CardiolTherapeutics #BiotechInvesting #ClinicalTrials #PharmaStocks #CBDTherapeutics #HeartHealth #StockMarket #InvestingInBiotech #HealthcareInnovation #OrphanDrug #Myocarditis #Pericarditis #FDAApproval #GrowthStocks #MedicalBreakthroughs